Uppsala: Immunotherapy and Biomarkers Take Center Stage Uppsala: Brainstorming Biomarkers Uppsala University, Sweden, played host to “Neurodegenerative Disorders—Immunotherapy and Biomarkers,” an international conference held 28-29 May 2009, and organized
A variety of approaches are beginning to home in on Aβ oligomers as drug targets, and some of them were showcased at the International Conference on Alzheimer’s Disease...
The ICAD featured that the interest in small Aβ aggregates has branched out far beyond the initial debates about whether they even exist and which forms are important...
The motor neurons and surrounding cells damaged in ALS cry out for assistance, and scientists are developing ways to home in on that need with growth factors that slow the degeneration process...
Anesthesia is meant to induce a temporary fog, lifting as soon as the drugs wear off. But for some, the effects linger, with delirium or confusion for days or weeks following surgery...
A new paper shows that stem cells are able to rehabilitate memory function in old mice with extensive AD pathology, but not by replacing lost neurons...
On the last morning of the International Conference on Alzheimer’s Disease (ICAD), investigators from different research groups marked a milestone in AD genetics...
On the heels of a report that tauopathy can be spread throughout the brain by the injection of a small amount of toxic tau comes a similar paper on the propagation of (Aβ)...
Vienna: New Genes, Anyone? ICAD Saves Best for Last Vienna: In Genetics, Bigger Is Better—Data Sharing Nets Three New Hits Vienna: Can a D-Peptide Turn Tiger Into Pussycat? Vienna: New Shoot Among Ashes of Drug Trials Vienna: New Tack to See Amyloid Oligo